Background The limited literature provides minimal information on clinical outcomes among patients undergoing percutaneous coronary intervention (PCI) under different healthcare funding systems, ...
Background Secondary prevention is critical for patients with established atherosclerotic cardiovascular diseases (ASCVD).
Background Anticoagulation non-adherence is attributed to myriad factors in patient populations across the world. While direct oral anticoagulants (DOACs) have demonstrated several clinical advantages ...
Background Previous studies have suggested an adverse role of epicardial adipose tissue (EAT) in aortic stenosis (AS), ...
Background Patients with heart failure (HF) and severe mitral regurgitation (MR) have poor outcomes. Early identification ...
Aims Heart failure (HF) often coexists with chronic kidney disease (CKD), impacting prognosis. This study aims to evaluate ...
Introduction Ischaemic heart disease (IHD) remains a leading cause of morbidity and mortality worldwide and poses an ...
APCU25CR28 Navigating dual diagnosis: case report of amyloid transthyretin (ATTR) cardiac amyloidosis and amyloid light-chain (AL) (13 February, 2026) ...
Background Heart failure (HF) readmission and mortality rates remain high among HF patients. Improved and robust risk prediction models for better monitoring, informed decision-making, targeted ...
Background Early graft failure within 90 postoperative days is the leading cause of mortality after heart transplantation. Existing risk scores, based on linear regression, often struggle to capture ...
Introduction Infective endocarditis (IE) remains challenging, and culture-negative IE (CNIE) complicates diagnosis by removing microbiological confirmation. Echocardiography is pivotal but can be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results